Navigation Links
Coherus Announces CHS-0214 (Proposed Etanercept Biosimilar) Meets Primary Endpoint In Pivotal Pharmacokinetic Clinical Study
Date:10/28/2013

"Etanercept is a very complex and challenging molecule.  Achieving this milestone demonstrates that Coherus' scientific and development capabilities enable us to compete successfully in the global biosimilars market across our portfolio," said Denny Lanfear, President and Chief Executive Officer of Coherus.

About Coherus Biosciences

Coherus Biosciences is a clinical stage, biosimilar biologics company headquartered in the San Francisco Bay Area.  The Company was founded by a group of biotech pioneers brought together by the shared vision of using their expertise and knowledge to increase global patient access to high quality, life changing biologic medications.  From conceptualization to commercialization, Coherus' unique business model leverages a strategic consortium of key service providers aligned through ownership and shared incentives. Coherus' global partnerships include top tier biopharma companies in Europe, Asia, and Latin America who are pursuing the integrated development and commercialization of products representing over $35 billion in current global sales.  Biosimilars are intended for use in place of existing, branded biologics to treat a range of chronic and often life-threatening diseases, and they have the potential to reduce costs and expand patient access.  For additional information, please visit www.coherus.com.

About Baxter International, Inc.

Baxter International, Inc., through its subsidiaries, develops, manufactures, and markets products that save and sustain the lives of people with hemophilia, immune disorders, cancer, infectious diseases, kidney disease, trauma, and other chronic and acute medical conditions.  As a global, diversified healthcare company, Baxter applies a unique combi
'/>"/>

SOURCE Coherus BioSciences
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Valeant Pharmaceuticals Announces Settlement Agreement With Anacor
2. Regulus Announces Significant Progress in Strategic Alliance with AstraZeneca and Selection of a New Pre-Clinically Validated microRNA Oncology Target
3. The Society of Pharmaceutical and Biotech Trainers Announces John Sjovall as New Board President
4. Volcano Announces Upcoming Data Presentations from Large-Scale Studies on Physiology and Imaging Technologies at TCT 2013
5. Comprehensive Care Corporation Announces Extension of $5 Million Credit Facility
6. VirtualScopics Board of Directors Appoints Eric Converse Interim Chief Executive Officer, Announces Resignation of Jeff Markin
7. MEI Pharma Announces Pricing of Public Offering of Common Stock
8. Sorrento Therapeutics Announces Pricing of Public Offering of 4,150,000 Shares of Common Stock and Listing on NASDAQ
9. Lilly announces Tapiero retiring; Zulueta promoted to senior vice president and president of Emerging Markets
10. Webcast Alert: Heska Announces Third Quarter 2013 Earnings Conference Call Webcast
11. IRIDEX Announces Third Quarter 2013 Conference Call and Release Date
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/25/2014)... -- Smile Train and its technology partner BioDigital have been ... among leading global health innovations in The Hive at ... Washington, D.C. at The John F. Kennedy ... Train is honored to be represented through our partnership ... health and medicine that TEDMED unites each year," said ...
(Date:7/25/2014)... -- CVS Caremark Corporation (NYSE: CVS ) will ... 2014, at 8:30 a.m. (EDT) with analysts and investors ... An audio webcast of the conference call will ... the CVS Caremark website for all interested parties.  To ... will be archived and available on the web site ...
(Date:7/25/2014)... Cardinal Health will today name three of the nation,s ... Independent Pharmacy Best Practices Competition, during the company,s ... gatherings of independent pharmacists. The Best ... Ohio , Tennessee and ... implementing exceptionally creative methods that demonstrate how independent pharmacies ...
Breaking Medicine Technology:Smile Train and BioDigital Selected to Showcase Virtual Surgery Simulator in The Hive at TEDMED 2014 2Smile Train and BioDigital Selected to Showcase Virtual Surgery Simulator in The Hive at TEDMED 2014 3Cardinal Health Announces Three Best Practice Winners for Leading Change in Community Pharmacy 2Cardinal Health Announces Three Best Practice Winners for Leading Change in Community Pharmacy 3Cardinal Health Announces Three Best Practice Winners for Leading Change in Community Pharmacy 4Cardinal Health Announces Three Best Practice Winners for Leading Change in Community Pharmacy 5Cardinal Health Announces Three Best Practice Winners for Leading Change in Community Pharmacy 6
... 1, 2012  Ultragenyx Pharmaceutical Inc., a biotechnology company ... genetic disorders, today announced results from a first-in-human, ... with hereditary inclusion body myopathy (HIBM) showing that ... profile on absorption after oral administration.  UX001 is ...
... (OTC Bulletin Board: NWBO ) (NW Bio) today announced ... received approval of a major grant from the Sachsische Aufbau ... will reimburse fifty percent (50%) of the costs for manufacturing ... for brain cancer at up to ...
Cached Medicine Technology:Ultragenyx Announces Phase 1 Results of UX001 in Hereditary Inclusion Body Myopathy (HIBM), a Rare Neuromuscular Disease 2Ultragenyx Announces Phase 1 Results of UX001 in Hereditary Inclusion Body Myopathy (HIBM), a Rare Neuromuscular Disease 3Northwest Bio Awarded $5.5 Million German Government Grant 2Northwest Bio Awarded $5.5 Million German Government Grant 3Northwest Bio Awarded $5.5 Million German Government Grant 4
(Date:7/26/2014)... According to the "Get Rid Tattoo Naturally" ... comprehensive guide that provides readers with safe and natural ... also teaches them how to fade dark colored tattoos, ... own home for drastic results. , Vkool reveals ... includes step-by-step tutorials and product recommendations for treating different ...
(Date:7/25/2014)... Staffordshire, UK (PRWEB) July 26, 2014 ... a variety of dental services including general dentistry, clear ... practice opening in September this year in Derby. The ... is at the HollyBrook Medical Centre in Littleover, Derby. ... the new practice. , The new dental practice, which ...
(Date:7/25/2014)... 2014 2014 Deep Research Report ... Industry” is a professional and in-depth research ... market. The report provides basic Laser Scanning ... Microscope definition, classification, application, and industry chain ... covers international market analysis, including China’s domestic market ...
(Date:7/25/2014)... 25, 2014 American motor vehicle owners ... collisions can pay higher premiums for vehicle insurance on ... insurer network to provide SR22 insurance for high risk ... The different coverage network of local agencies providing direct ... search platform now publicly available for any car owner ...
(Date:7/25/2014)... 25, 2014 As reported by the New ... Marijuana Increasing (7/3), the state of Louisiana has recently ... so even than cocaine. Officials believe the increase is due ... a “form” of marijuana. However, both doctors and police confirm ... far as to call it “poison,” doctors have acknowledged that ...
Breaking Medicine News(10 mins):Health News:"Get Rid Tattoo Naturally" Book Review Exposes Jason Carter's Tattoo Removal Guide – Vkool.com 2Health News:"Get Rid Tattoo Naturally" Book Review Exposes Jason Carter's Tattoo Removal Guide – Vkool.com 3Health News:Derby Cosmetic Dentist Dental Perfection to Open New Practice in Littleover, Derby this September 2Health News:Laser Scanning Confocal Microscope Market: 2014 Global, China Manufacturing Bases Analysis Now at DeepResearchReports.com 2Health News:Laser Scanning Confocal Microscope Market: 2014 Global, China Manufacturing Bases Analysis Now at DeepResearchReports.com 3Health News:Laser Scanning Confocal Microscope Market: 2014 Global, China Manufacturing Bases Analysis Now at DeepResearchReports.com 4Health News:SR22 Insurance for High Risk Motorists Added to Local Quotes System at Insurer Website Online 2Health News:Louisiana Recognizes Dangers of Synthetic Marijuana 2
... THURSDAY, Nov. 18 (HealthDay News) -- New research supports the ... may not have an increased risk for cancer, as some ... drugs for people with high blood cholesterol levels, which are ... Zocor. "Three or four years ago there was a ...
... survey from The Commonwealth Fund finds that adults in the ... other industrialized nations to go without health care because of ... even when insured, and have disputes with their insurers or ... report, the findings highlight the need for Affordable Care Act ...
... vitamin D receptors on cancer cells has prompted encouraging ... in men with prostate cancer that has become resistant ... II(a) clinical trial will be presented at the 22nd ... in Berlin today (Thursday). The trial found that when ...
... cancer cells to repair damage to their DNA has shown ... patients with a range of solid tumours, many of whom ... have seen their tumours shrink or stabilise for periods of ... will be presented at the 22nd EORTC-NCI-AACR [1] Symposium on ...
... November 2, 2010) Uniting Against Lung Cancer (Uniting) announces ... Research." This year,s recipient is Avrum Spira, M.D., ... and Director, Translational Bioinformatics Program, Clinical and Translational Science ... is intended for the research lab and its leader ...
... of the Care New England health care system, recently unveiled ... immediate action if they have concerns about the care being ... called the Family Activated Safety Team (FAST) at Kent and ... will serve as a resource for patients and family members ...
Cached Medicine News:Health News:Long-Term Statin Use Won't Up Cancer Risk: Study 2Health News:US adults most likely to forgo care due to cost, have trouble paying medical bills 2Health News:US adults most likely to forgo care due to cost, have trouble paying medical bills 3Health News:US adults most likely to forgo care due to cost, have trouble paying medical bills 4Health News:US adults most likely to forgo care due to cost, have trouble paying medical bills 5Health News:New drug targets vitamin D receptors in hormone resistant prostate cancers 2Health News:New drug targets vitamin D receptors in hormone resistant prostate cancers 3Health News:PARP inhibitor, MK-4827, shows anti-tumor activity in first trial in humans 2Health News:PARP inhibitor, MK-4827, shows anti-tumor activity in first trial in humans 3Health News:Boston University researcher lauded for leading-edge lung cancer research efforts 2Health News:Hospitals introduce family-activated rapid response programs 2
... with Two Large Working Channels; 33 cm ... Ureteroscope is the smallest ureteroscope with two ... procedures. The ACMI MICRO-6 Ureteroscope reduces patient ... minimal or no dilation or general anesthesia. ...
... ACMI MRO-742A is a self-dilating, semi-rigid autoclavable ... large, high-density image bundle for an enhanced, ... is preset to "0" diopters. The direction ... safe instrument passage. The straight access operating ...
... features a tip diameter of only ... up/down angulation range of 180 for ... areas.,For improved observation, a new optical ... reusable 11.7Fr (3.9mm) sheath dilator, 0.035" ...
... Durable Flexible Ureteroscope permits direct visualization and ... with little or no dilation.,A tight bend ... intrarenal access, including the lower pole calyces. ... ureter and the renal pelvis. The 6.75 ...
Medicine Products: